XML 25 R19.htm IDEA: XBRL DOCUMENT

Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2024

Disclosure Of Balance Sheet Components [Abstract]

Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statements of cash flows (in thousands):


		March 31, 2024				December 31, 2023
Cash		$	11,451			$	8,488
Cash equivalents			140,490				216,622
Cash and cash equivalents			151,941				225,110
Restricted cash			1,032				1,032
Cash, cash equivalents and restricted cash		$	152,973			$	226,142

Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


		March 31, 2024				December 31, 2023
Prepaid research and development costs		$	4,643			$	2,617
Prepaid insurance			418				704
Other prepaid expenses			708				760
Other current assets			23				63
Total prepaid expenses and other current assets		$	5,792			$	4,144

Summary of Property and Equipment, Net

Property and equipment, net, consisted of the following (in thousands):


		March 31, 2024				December 31, 2023
Leasehold improvements		$	17,246			$	17,245
Laboratory equipment			1,832				1,832
Furniture and fixtures			692				692
Computer equipment and software			33				33
Total property and equipment, gross			19,803				19,802
Less: accumulated depreciation			(5,568	)			(5,029	)
Total property and equipment, net		$	14,235			$	14,773

Summary of Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):


		March 31, 2024				December 31, 2023
Accrued research and development expenses		$	4,527			$	4,027
Accrued compensation			1,643				5,607
Accrued professional services			570				501
Other accrued expenses			117				100
Total accrued liabilities		$	6,857			$	10,235